ReviewMetabolic brain disease2020
The salvageable brain in acute ischemic stroke. The concept of a reverse mismatch: a mini-review.
Review in Metabolic brain disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Keap1-Nrf2/ARE signal pathway activated by butylphthalide in the treatment of ischemic stroke.American journal of translational research · 2022Article
- Blood Pressure Management in Acute Ischemic Stroke.Current hypertension reports · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent studies have opened a new era in treatment of acute ischemic stroke, enabling thrombolysis or thrombectomy far beyond the standard therapeutic "time windows". These therapeutic protocols are built on various combinations of perfusion parameters, lesion volume, and neurological assessment. However, on top of the brain perfusion, there are other multiple factors that might modify the probability of neuronal apoptosis and necrosis following focal cerebral ischemia. We hypothesize that a diagnostic approach with measurements of selected biochemical parameters in the brain, in addition to those based solely on perfusion or MR diffusion, might allow for more personalized management protocols. Moreover, some local processes in the brain, triggered by acute ischemia or its consequences other than hypoperfusion directly, like, for example, excitotoxicity, might lead to apoptosis of the cells in the brain localized also beyond the area of hypoperfusion. This phenomenon might be responsible for the expansion of the brain damage much beyond the initial perfusion deficit or beyond the initial diffusion (DWI) restriction area, reported for example in T2W or FLAIR MRI in some stroke patients who have no other reasons to deteriorate (a reverse DWI - T2W / FLAIR, a reverse perfusion - DWI, or a reverse DWI - DWI mismatch).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.